This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Google Healthcare Startup Calico Partners With Abbvie

09/03/14 - 01:19 PM EDT

Under the agreement, Calico and Abbvie will work together to discover and develop new drugs for age-related diseases, including neuro-degeneration and cancer.

READ FULL POST

Sunesis Takes a Run Through the Feuerstein-Ratain Rule

09/02/14 - 10:29 AM EDT

Results from Sunesis' phase III study in acute myeloid leukemia should be released this month or next.

READ FULL POST

Biotech Stock Boom Times Are Back

08/26/14 - 07:00 AM EDT

The iShares Nasdaq Biotechnology ETF closed at 272.63 Monday, less than one point below the year (and all-time) closing high reached on Feb. 25.

READ FULL POST

Galena Fires CEO Ahn, Offers No Parting Gifts

08/25/14 - 08:48 AM EDT

CEOs who leave companies on good terms get cushy severance packages. Galena's Ahn did not.

READ FULL POST

Ampio: The Freezer Killed My Osteoarthritis Drug

08/21/14 - 10:23 AM EDT

Ampio Pharmaceuticals is blaming a mini Polar Vortex for blowing up a pivotal study of its osteoarthritis drug Ampion.

READ FULL POST

Northwest Bio Can't Keep Its DC-Vax Claims Straight

08/14/14 - 10:20 AM EDT

Contradictory statements made on whether or not Northwest Bio conducted an interim analysis of its DC-Vax phase III study.

READ FULL POST

Blame MannKind's Fall on its Bloated Balance Sheet

08/13/14 - 12:04 PM EDT

Even in biotech where the "blue sky" potential for experimental drugs so often sends stock prices soaring, no company can escape the gravitational pull of balance sheets and income statements.

READ FULL POST

Arrowhead Discloses First Human Hepatitis B Therapy Results

08/12/14 - 05:11 PM EDT

The announcement is short on specific details but the Arrowhead drug, ARC-520, appears to have passed through its first clinical hurdle in hepatitis B patients relatively well.

READ FULL POST

Dendreon Warns Debt Bomb Might Wipe Out Shareholders

08/12/14 - 07:17 AM EDT

The struggling Provenge peddler is suffocating under $620 million in debt and the bill comes soon.

READ FULL POST

Intercept Pharma Shares Higher on Positive Fatty Liver Drug Data

08/11/14 - 05:29 PM EDT

Intercept's OCA data look good. I don't see anything in the study results which scream, "RUN AWAY!" This is what some investors feared, causing the stock price to fall recently.

READ FULL POST

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.95 -3.87 -0.18%
NASDAQ 5,090.7350 -0.0590 -0.00%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs